- Home
- UBCP vs QTTB Comparison
UBCP vs QTTB Comparison
Compare UBCP & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UBCP | QTTB |
|---|---|---|
| Founded | 1902 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.5M | 97.5M |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | UBCP | QTTB |
|---|---|---|
| Price | $15.99 | $11.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 9.3K | ★ 1.4M |
| Earning Date | 05-08-2026 | 05-14-2026 |
| Dividend Yield | ★ 5.73% | N/A |
| EPS Growth | 5.51 | ★ 136.78 |
| EPS | ★ 0.33 | N/A |
| Revenue | N/A | ★ $53,737,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.58 | N/A |
| P/E Ratio | $48.45 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.47 | $1.40 |
| 52 Week High | $17.34 | $14.85 |
Technical Indicators
Market Signals| Indicator | UBCP | QTTB |
|---|---|---|
| Relative Strength Index (RSI) | 54.18 | 57.73 |
| Support Level | $14.86 | $2.93 |
| Resistance Level | $16.12 | $14.85 |
| Average True Range (ATR) | 0.37 | 1.56 |
| MACD | 0.01 | -0.15 |
| Stochastic Oscillator | 73.88 | 27.43 |
Price Performance
Historical ComparisonAbout UBCP United Bancorp Inc.
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which includes accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. It serves customers in Belmont, Harrison, Jefferson, Tuscarawas, Carroll, Athens, Hocking, and Fairfield counties and the surrounding localities. The bank also operates in Marshall County West Virginia.
About QTTB Q32 Bio Inc.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).